176 related articles for article (PubMed ID: 26512875)
1. Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models.
Ligat L; Saint-Laurent N; El-Mrani A; Gigoux V; Al Saati T; Tomasini R; Nigri J; Dejean S; Pont F; Baer R; Guillermet-Guibert J; Cordelier P; Lopez F; Dufresne M
Br J Cancer; 2015 Dec; 113(11):1590-8. PubMed ID: 26512875
[TBL] [Abstract][Full Text] [Related]
2. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.
LaConti JJ; Laiakis EC; Mays AD; Peran I; Kim SE; Shay JW; Riegel AT; Fornace AJ; Wellstein A
BMC Genomics; 2015; 16 Suppl 1(Suppl 1):S1. PubMed ID: 25923219
[TBL] [Abstract][Full Text] [Related]
3. Metabonomic changes from pancreatic intraepithelial neoplasia to pancreatic ductal adenocarcinoma in tissues from rats.
Wen S; Li Z; Feng J; Bai J; Lin X; Huang H
Cancer Sci; 2016 Jun; 107(6):836-45. PubMed ID: 27019331
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
[TBL] [Abstract][Full Text] [Related]
5. EGFR expression in pancreatic intraepithelial neoplasia and ductal adenocarcinoma.
Park SJ; Gu MJ; Lee DS; Yun SS; Kim HJ; Choi JH
Int J Clin Exp Pathol; 2015; 8(7):8298-304. PubMed ID: 26339400
[TBL] [Abstract][Full Text] [Related]
6. Cancerization of the Pancreatic Ducts: Demonstration of a Common and Under-recognized Process Using Immunolabeling of Paired Duct Lesions and Invasive Pancreatic Ductal Adenocarcinoma for p53 and Smad4 Expression.
Hutchings D; Waters KM; Weiss MJ; Wolfgang CL; Makary MA; He J; Cameron JL; Wood LD; Hruban RH
Am J Surg Pathol; 2018 Nov; 42(11):1556-1561. PubMed ID: 30212393
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.
Xue Y; Abou Tayoun AN; Abo KM; Pipas JM; Gordon SR; Gardner TB; Barth RJ; Suriawinata AA; Tsongalis GJ
Cancer Genet; 2013 Jun; 206(6):217-21. PubMed ID: 23933230
[TBL] [Abstract][Full Text] [Related]
8. The biological features of PanIN initiated from oncogenic Kras mutation in genetically engineered mouse models.
Shen R; Wang Q; Cheng S; Liu T; Jiang H; Zhu J; Wu Y; Wang L
Cancer Lett; 2013 Oct; 339(1):135-43. PubMed ID: 23887057
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic intraepithelial neoplasia-can we detect early pancreatic cancer?
Haugk B
Histopathology; 2010 Oct; 57(4):503-14. PubMed ID: 20875068
[TBL] [Abstract][Full Text] [Related]
10. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models.
Cruz-Monserrate Z; Abd-Elgaliel WR; Grote T; Deng D; Ji B; Arumugam T; Wang H; Tung CH; Logsdon CD
Gut; 2012 Sep; 61(9):1315-22. PubMed ID: 22068166
[TBL] [Abstract][Full Text] [Related]
11. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer.
Grüner BM; Hahne H; Mazur PK; Trajkovic-Arsic M; Maier S; Esposito I; Kalideris E; Michalski CW; Kleeff J; Rauser S; Schmid RM; Küster B; Walch A; Siveke JT
PLoS One; 2012; 7(6):e39424. PubMed ID: 22761793
[TBL] [Abstract][Full Text] [Related]
12. Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.
Aichler M; Seiler C; Tost M; Siveke J; Mazur PK; Da Silva-Buttkus P; Bartsch DK; Langer P; Chiblak S; Dürr A; Höfler H; Klöppel G; Müller-Decker K; Brielmeier M; Esposito I
J Pathol; 2012 Apr; 226(5):723-34. PubMed ID: 21984419
[TBL] [Abstract][Full Text] [Related]
13. [New insights into the origin of pancreatic cancer. Role of atypical flat lesions in pancreatic carcinogenesis].
Esposito I; Konukiewitz B; Schlitter AM; Klöppel G
Pathologe; 2012 Nov; 33 Suppl 2():189-93. PubMed ID: 23011021
[TBL] [Abstract][Full Text] [Related]
14. Expression of urocortin in pancreatic ductal adenocarcinoma and pancreatic intraepithelial neoplasia.
Cheng MF; Tsai WC; Hsia KT; Yang YS; Jin JS
APMIS; 2014 Feb; 122(2):147-54. PubMed ID: 23755913
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
16. Hypothetical progression model of pancreatic cancer with origin in the centroacinar-acinar compartment.
Esposito I; Seiler C; Bergmann F; Kleeff J; Friess H; Schirmacher P
Pancreas; 2007 Oct; 35(3):212-7. PubMed ID: 17895840
[TBL] [Abstract][Full Text] [Related]
17. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
18. The Prevalence and Clinicopathological Characteristics of High-Grade Pancreatic Intraepithelial Neoplasia: Autopsy Study Evaluating the Entire Pancreatic Parenchyma.
Matsuda Y; Furukawa T; Yachida S; Nishimura M; Seki A; Nonaka K; Aida J; Takubo K; Ishiwata T; Kimura W; Arai T; Mino-Kenudson M
Pancreas; 2017; 46(5):658-664. PubMed ID: 28196020
[TBL] [Abstract][Full Text] [Related]
19. Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancer.
Waldmann J; Fendrich V; Reichert M; Hecker A; Bartsch DK; Padberg W; Holler JPN
J Surg Res; 2018 Mar; 223():230-236. PubMed ID: 29433879
[TBL] [Abstract][Full Text] [Related]
20. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
